ReP USP - Resultado da busca

Artigo de periodico
Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo (2022)
Pandey, Ramendra Pati; Nascimento, Marilda Savoia ; Franco, Caio Haddad ; Bortoluci, Karina ; Silva, Marcelo Nunes da ; Zingales, Bianca ; Gibald, Daniel; Barrios, Leda Castaño; Vieira, Joseli Lannes ; Cariste, Leonardo Moro; Vasconcelos, Jose Ronnie ; Moraes, Carolina Borsoi ; Freitas Junior, Lucio H; Kalil Filho, Jorge Elias ; Alcântara, Laura; Cunha Neto, Edecio
Source: Antimicrobial Agents and Chemotherapy. Unidades: FM, IQ
Subjects: DOENÇA DE CHAGAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PANDEY, Ramendra Pati et al. Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo. Antimicrobial Agents and Chemotherapy, v. 66, n. 11, p. 1-17, 2022Tradução . . Disponível em: https://doi.org/10.1128/aac.00284-22. Acesso em: 19 nov. 2024.
APA
Pandey, R. P., Nascimento, M. S., Franco, C. H., Bortoluci, K., Silva, M. N. da, Zingales, B., et al. (2022). Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo. Antimicrobial Agents and Chemotherapy, 66( 11), 1-17. doi:10.1128/aac.00284-22
NLM
Pandey RP, Nascimento MS, Franco CH, Bortoluci K, Silva MN da, Zingales B, Gibald D, Barrios LC, Vieira JL, Cariste LM, Vasconcelos JR, Moraes CB, Freitas Junior LH, Kalil Filho JE, Alcântara L, Cunha Neto E. Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo [Internet]. Antimicrobial Agents and Chemotherapy. 2022 ; 66( 11): 1-17.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1128/aac.00284-22
Vancouver
Pandey RP, Nascimento MS, Franco CH, Bortoluci K, Silva MN da, Zingales B, Gibald D, Barrios LC, Vieira JL, Cariste LM, Vasconcelos JR, Moraes CB, Freitas Junior LH, Kalil Filho JE, Alcântara L, Cunha Neto E. Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo [Internet]. Antimicrobial Agents and Chemotherapy. 2022 ; 66( 11): 1-17.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1128/aac.00284-22
Artigo de periodico
Genomic characterization of mcr-1.1-Producing Escherichia coli recovered from human infections in São Paulo, Brazil (2021)
Girardello, Raquel; Piroupo, Carlos Morais ; Martins Junior, Joaquim ; Maffucci, Marcia Helena; Cury, Ana Paula; Franco, Maria Renata Gomes; Malta, Fernanda de Mello ; Rocha, Natália Conceição ; Pinho, Joao Renato Rebello ; Rossi, Flávia; Duarte, Alberto José da Silva; Setubal, João Carlos
Source: Frontiers in Microbiology. Unidades: IQ, FM
Subjects: ESCHERICHIA COLI, ANTIBIÓTICOS, PLASMÍDEOS, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIRARDELLO, Raquel et al. Genomic characterization of mcr-1.1-Producing Escherichia coli recovered from human infections in São Paulo, Brazil. Frontiers in Microbiology, v. 12, p. 1-9 art. 663414, 2021Tradução . . Disponível em: https://doi.org/10.3389/fmicb.2021.663414. Acesso em: 19 nov. 2024.
APA
Girardello, R., Piroupo, C. M., Martins Junior, J., Maffucci, M. H., Cury, A. P., Franco, M. R. G., et al. (2021). Genomic characterization of mcr-1.1-Producing Escherichia coli recovered from human infections in São Paulo, Brazil. Frontiers in Microbiology, 12, 1-9 art. 663414. doi:10.3389/fmicb.2021.663414
NLM
Girardello R, Piroupo CM, Martins Junior J, Maffucci MH, Cury AP, Franco MRG, Malta F de M, Rocha NC, Pinho JRR, Rossi F, Duarte AJ da S, Setubal JC. Genomic characterization of mcr-1.1-Producing Escherichia coli recovered from human infections in São Paulo, Brazil [Internet]. Frontiers in Microbiology. 2021 ; 12 1-9 art. 663414.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fmicb.2021.663414
Vancouver
Girardello R, Piroupo CM, Martins Junior J, Maffucci MH, Cury AP, Franco MRG, Malta F de M, Rocha NC, Pinho JRR, Rossi F, Duarte AJ da S, Setubal JC. Genomic characterization of mcr-1.1-Producing Escherichia coli recovered from human infections in São Paulo, Brazil [Internet]. Frontiers in Microbiology. 2021 ; 12 1-9 art. 663414.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fmicb.2021.663414
Artigo de periodico
Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil? (2017)
Rossi, Flávia; Girardello, Raquel; Morais, Carlos; Cury, Ana Paula; Martins, Layla Farage; Da Silva, Aline Maria ; Abdala, Edson; Setubal, João Carlos ; Duarte, Alberto José da Silva
Source: Clinics. Unidades: IQ, FM
Subjects: ESCHERICHIA COLI, GENOMAS, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSSI, Flávia et al. Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil?. Clinics, v. 72, n. 10, p. 642-644, 2017Tradução . . Disponível em: https://doi.org/10.6061/clinics/2017(10)09. Acesso em: 19 nov. 2024.
APA
Rossi, F., Girardello, R., Morais, C., Cury, A. P., Martins, L. F., Da Silva, A. M., et al. (2017). Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil? Clinics, 72( 10), 642-644. doi:10.6061/clinics/2017(10)09
NLM
Rossi F, Girardello R, Morais C, Cury AP, Martins LF, Da Silva AM, Abdala E, Setubal JC, Duarte AJ da S. Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil? [Internet]. Clinics. 2017 ; 72( 10): 642-644.[citado 2024 nov. 19 ] Available from: https://doi.org/10.6061/clinics/2017(10)09
Vancouver
Rossi F, Girardello R, Morais C, Cury AP, Martins LF, Da Silva AM, Abdala E, Setubal JC, Duarte AJ da S. Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil? [Internet]. Clinics. 2017 ; 72( 10): 642-644.[citado 2024 nov. 19 ] Available from: https://doi.org/10.6061/clinics/2017(10)09

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects